Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Sterling eases off recent highs as vaccine optimism fades

Thu, 28th Jan 2021 12:23

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv
(Updates prices, adds commentary and detail)

By Elizabeth Howcroft

LONDON, Jan 28 (Reuters) - The British pound retreated on
Thursday from the previous session's multi-month highs, as
investors tempered some of their optimism about the UK vaccine
rollout, with the lockdown in England set to last until at least
March.

Sterling surged to its highest since May 2018 against the
dollar in early London trading on Wednesday and later reached an
eight-month high against the euro - a move analysts attributed
to the UK rolling out vaccines faster than continental Europe.

But concern about vaccine rollouts globally, and the impact
of mutations of the virus, created a cautious tone in markets,
and a stronger dollar, which meant that the British currency
eased off these highs on Thursday.

"In this environment, everything is pointing towards refuge
in the dollar, even if the moves are marginal in today's trading
session," said Simon Harvey, an FX strategist at Monex Europe.

"The pound is not sheltered from this strong USD
environment, despite the UK's aggressive rate of vaccine
distribution, although it remains relatively robust against
other G10 peers," he said.

Britain said on Thursday it must get all the COVID-19
vaccines it had ordered and paid for, after some European Union
politicians asked drugmaker AstraZeneca to divert doses from the
UK to make up for a shortfall in supplies.

At 1156 GMT, the pound was down 0.2% against a stronger
dollar, at $1.3661, compared with its Wednesday high of $1.3759
. Versus the euro, it was down around 0.2% at 88.59
pence per euro, after peaking at 88.135 in the previous session
.

"We consider sterling optimism to be excessive and we see
the risk of disappointed expectations. We therefore urge caution
about betting on further sterling gains," wrote Commerzbank FX
strategist You-Na Park-Heger in a note to clients.

"The markets are clearly ignoring that the current infection
situation in the UK is still very tense," she said. "There is a
high degree of uncertainty as it is difficult to say how the
pandemic is going to develop short-term and when and how quickly
the restrictions can be eased."

Britain has the world's fifth highest death toll from
COVID-19, and Prime Minister Boris Johnson has indicated that
the strict COVID-19 lockdown in England will last until March 8.

British households have cut debit and credit card spending
sharply and the proportion of workers on furlough has risen to
its highest since July after new coronavirus lockdown
restrictions came into force earlier this month.
(Reporting by Elizabeth Howcroft; editing by William Maclean,
Larry King)

More News
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more
22 Sep 2023 07:27

AstraZeneca reports positive findings from breast cancer threatment trial

(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.

Read more
20 Sep 2023 08:44

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.

Read more
15 Sep 2023 15:27

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.

Read more
14 Sep 2023 08:25

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.